- Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer. BMC cancer. 2016 In Process GET IT
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
Proceedings of the National Academy of Sciences of the United States of America.
Times cited: 322
- Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer cell. 2005 Academic Article GET IT